SOX11 是 cyclin D1 阴性套细胞淋巴瘤的一个生物标志物。
SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma.
机构信息
Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY 10595 USA.
出版信息
Biomark Res. 2016 Mar 3;4:6. doi: 10.1186/s40364-016-0060-9. eCollection 2016.
Abstract
Cyclin D1 (CCND1) protein overexpression and/or the t(11;14)(q13;q32) translocation are the pathognomonic hallmarks of mantle cell lymphoma (MCL). However, there have been cases that lacked both t(11;14) and cyclin D1 protein but still had a gene expression profile suggesting a diagnosis of MCL. SOX11 expression was detected in most cyclin D1- negative MCL and can serve as a specific biomarker for the diagnosis of this subset of MCL. Lack of SOX11 expression in MCL was associated with an indolent subset and favorable prognosis.
摘要
Cyclin D1 (CCND1) 蛋白过表达和/或 t(11;14)(q13;q32) 易位是套细胞淋巴瘤 (MCL) 的特征性标志。然而，有些病例既缺乏 t(11;14)，也缺乏 cyclin D1 蛋白，但仍具有基因表达谱提示 MCL 的诊断。SOX11 在大多数 cyclin D1 阴性的 MCL 中表达，可作为该亚组 MCL 的特异性诊断标志物。MCL 中缺乏 SOX11 表达与惰性亚组和良好预后相关。
相似文献
1
SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma.SOX11 是 cyclin D1 阴性套细胞淋巴瘤的一个生物标志物。
Biomark Res. 2016 Mar 3;4:6. doi: 10.1186/s40364-016-0060-9. eCollection 2016.
2
SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?SOX11 阳性大 B 细胞肿瘤：Cyclin D1 阴性淋巴母细胞样/多形性套细胞淋巴瘤还是大 B 细胞淋巴瘤？
Mod Pathol. 2024 Feb;37(2):100405. doi: 10.1016/j.modpat.2023.100405. Epub 2023 Dec 15.
3
Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms.Sox11 的核表达与套细胞淋巴瘤高度相关，但与非套细胞 B 细胞肿瘤中的 t(11;14)(q13;q32)无关。
Mod Pathol. 2010 Jan;23(1):105-12. doi: 10.1038/modpathol.2009.140. Epub 2009 Oct 2.
4
Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.SOX11 表达鉴定的 Cyclin D1 阴性原始神经外胚层肿瘤样套细胞淋巴瘤。
Am J Surg Pathol. 2012 Feb;36(2):214-9. doi: 10.1097/PAS.0b013e318241f050.
5
The pathologic diagnosis of mantle cell lymphoma.套细胞淋巴瘤的病理诊断。
Histol Histopathol. 2021 Oct;36(10):1037-1051. doi: 10.14670/HH-18-351. Epub 2021 Jun 11.
6
and hijack immunoglobulin light-chain enhancers in cyclin D1 mantle cell lymphoma.并劫持免疫球蛋白轻链增强子在套细胞淋巴瘤中的 cyclin D1 中。
Blood. 2019 Feb 28;133(9):940-951. doi: 10.1182/blood-2018-07-862151. Epub 2018 Dec 11.
7
Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.SOX11及与细胞周期蛋白D1协同作用的基因事件在套细胞淋巴瘤中的作用
Curr Oncol Rep. 2017 Jun;19(6):43. doi: 10.1007/s11912-017-0598-1.
8
A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.一种用于定量检测套细胞淋巴瘤生物标志物 SOX11 的高灵敏和特异的 qPCR 检测方法。
Eur J Haematol. 2012 Nov;89(5):385-94. doi: 10.1111/j.1600-0609.2012.01837.x. Epub 2012 Aug 21.
9
Mantle cell lymphoma--a spectrum from indolent to aggressive disease.套细胞淋巴瘤——一种从惰性到侵袭性疾病的谱系。
Virchows Arch. 2016 Mar;468(3):245-57. doi: 10.1007/s00428-015-1840-6. Epub 2015 Aug 23.
10
SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.SOX11 在鉴别 cyclin D1 阳性弥漫性大 B 细胞淋巴瘤与套细胞淋巴瘤方面是有用的。
Histopathology. 2012 Oct;61(4):685-93. doi: 10.1111/j.1365-2559.2012.04260.x.
引用本文的文献
1
Case report: Identification of atypical mantle cell lymphoma with rearrangement by next-generation sequencing.病例报告：通过二代测序鉴定伴有重排的非典型套细胞淋巴瘤。
Front Oncol. 2023 Mar 29;13:1145376. doi: 10.3389/fonc.2023.1145376. eCollection 2023.
2
The Effectiveness of Dual-Staining Immunohistochemistry in the Detection of Mantle Cell Lymphoma in the Bone Marrow.双重免疫组织化学染色在骨髓中检测套细胞淋巴瘤的有效性。
Am J Clin Pathol. 2022 May 4;157(5):709-717. doi: 10.1093/ajcp/aqab179.
3
Case report of primary CD20 negative diffuse large B-cell lymphoma.原发性CD20阴性弥漫性大B细胞淋巴瘤病例报告
Oxf Med Case Reports. 2021 Nov 25;2021(11):omab114. doi: 10.1093/omcr/omab114. eCollection 2021 Nov.
4
Non-chemotherapy Options for Newly Diagnosed Mantle Cell Lymphoma.新诊断的套细胞淋巴瘤的非化疗选择。
Curr Treat Options Oncol. 2021 Sep 15;22(11):98. doi: 10.1007/s11864-021-00900-w.
5
Mantle Cell Lymphoma Presenting as Acute Abdominal Syndrome: A Rare Case Report and Literature Review.表现为急性腹部综合征的套细胞淋巴瘤：1例罕见病例报告及文献复习
Healthcare (Basel). 2021 Aug 5;9(8):1000. doi: 10.3390/healthcare9081000.
6
Migration and Adhesion of B-Lymphocytes to Specific Microenvironments in Mantle Cell Lymphoma: Interplay between Signaling Pathways and the Epigenetic Landscape.套细胞淋巴瘤中 B 淋巴细胞向特定微环境的迁移和黏附：信号通路与表观遗传景观的相互作用。
Int J Mol Sci. 2021 Jun 10;22(12):6247. doi: 10.3390/ijms22126247.
7
Mantle cell lymphoma with diminished expression of B-cell antigens: an unusual presentation.B细胞抗原表达降低的套细胞淋巴瘤：一种不寻常的表现。
BMJ Case Rep. 2020 Jul 16;13(7):e235561. doi: 10.1136/bcr-2020-235561.
8
Cyclin D1 + large B-cell lymphoma with altered CCND1 and BCL-6 rearrangements: a diagnostic challenge.伴有CCND1改变和BCL-6重排的细胞周期蛋白D1阳性大B细胞淋巴瘤：诊断挑战
Biomark Res. 2019 Jun 3;7:11. doi: 10.1186/s40364-019-0162-2. eCollection 2019.
9
Current trials for frontline therapy of mantle cell lymphoma.当前用于治疗套细胞淋巴瘤的一线疗法的临床试验。
J Hematol Oncol. 2018 Jan 27;11(1):13. doi: 10.1186/s13045-018-0556-x.
10
Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004).来那度胺治疗伊布替尼治疗后复发/进展或不耐受/难治的套细胞淋巴瘤患者的观察性研究（MCL-004）。
J Hematol Oncol. 2017 Nov 2;10(1):171. doi: 10.1186/s13045-017-0537-5.
本文引用的文献
1
SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6.SOX11通过对BCL6的转录调控定义了套细胞淋巴瘤的两种不同亚型。
Leukemia. 2016 Jul;30(7):1596-9. doi: 10.1038/leu.2015.355. Epub 2015 Dec 29.
2
Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype.浆细胞和终末 B 细胞分化主要发生在套细胞淋巴瘤的 SOX11 阴性亚型中。
Mod Pathol. 2015 Nov;28(11):1435-47. doi: 10.1038/modpathol.2015.99. Epub 2015 Sep 11.
3
The utility of mRNA analysis in defining SOX11 expression levels in mantle cell lymphoma and reactive lymph nodes.mRNA分析在确定套细胞淋巴瘤和反应性淋巴结中SOX11表达水平方面的效用。
Haematologica. 2015 Sep;100(9):e369-72. doi: 10.3324/haematol.2015.123885. Epub 2015 Apr 17.
4
The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples.SOX11免疫染色在细针穿刺样本中确诊套细胞淋巴瘤的作用。
Cancer Cytopathol. 2014 Dec;122(12):892-7. doi: 10.1002/cncy.21465. Epub 2014 Jul 23.
5
A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.一种用于定量检测套细胞淋巴瘤生物标志物 SOX11 的高灵敏和特异的 qPCR 检测方法。
Eur J Haematol. 2012 Nov;89(5):385-94. doi: 10.1111/j.1600-0609.2012.01837.x. Epub 2012 Aug 21.
6
Expanded clinical and experimental use of SOX11 - using a monoclonal antibody.SOX11 的临床和实验应用拓展——使用单克隆抗体。
BMC Cancer. 2012 Jun 27;12:269. doi: 10.1186/1471-2407-12-269.
7
Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma.SOX11 在基于人群的套细胞淋巴瘤队列中的预后作用。
Blood. 2012 May 3;119(18):4215-23. doi: 10.1182/blood-2011-12-400580. Epub 2012 Mar 19.
8
Indolent mantle cell lymphoma.惰性套细胞淋巴瘤
Haematologica. 2011 Aug;96(8):1086-8. doi: 10.3324/haematol.2011.047357.
9
WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview.2008年世界卫生组织造血与淋巴组织肿瘤分类概述
Pathologica. 2010 Jun;102(3):83-7.
10
Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.基因组和基因表达谱分析定义了惰性形式的套细胞淋巴瘤。
Cancer Res. 2010 Feb 15;70(4):1408-18. doi: 10.1158/0008-5472.CAN-09-3419. Epub 2010 Feb 2.
Zotero 插件